Search research articles
Contact Us
Filters
Showing results (341-350 of 471) with videos related to
Page
of 48
Sort By:
American Journal of Hematology
|
June 1, 2010
A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma
Angela Dispenzieri, Gregory A Wiseman, Martha Q Lacy, et al.
Blood
|
April 17, 2012
Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial
Shaji K Kumar, Suzanne R Hayman, Francis K Buadi, et al.
Research Square
|
April 17, 2026
Risk of AL Amyloidosis is Associated with Degree of Free Light Chain Elevation and Duration of Exposure
Angela Dispenzieri, Maximilian Steinhardt, Eli Muchtar, et al.
British Journal of Haematology
|
November 20, 2020
Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma
Jithma P Abeykoon, David L Murray, Isaiah Murray, et al.
European Journal of Haematology
|
November 24, 2020
Characterization and prognostic implication of delayed complete response in AL amyloidosis
Eli Muchtar, Morie A Gertz, Shaji K Kumar, et al.
American Journal of Hematology
|
July 19, 2020
Refining amyloid complete hematological response: Quantitative serum free light chains superior to ratio
Eli Muchtar, Morie A Gertz, Martha Q Lacy, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 29, 2025
Dose Delays and Treatment Interruptions Secondary to Ocular Toxicity From BCMA-Directed Antibody Drug Conjugate Therapy in Relapsed Multiple Myeloma
Matthew J Rees, Timothy T Xu, Suheil Albert Atallah-Yunes, et al.
American Journal of Hematology
|
October 4, 2025
Clinical Characteristics, Treatment Responses and Outcomes of Light Chain Multiple Myeloma
Abiola Bolarinwa, Saurabh Zanwar, Nadine Abdallah, et al.
Blood Advances
|
January 30, 2025
Solitary plasmacytoma: single-institution experience, and systematic review and meta-analysis of clinical outcomes
Charalampos Charalampous, Jean-Sebastien Claveau, Prashant Kapoor, et al.
JCO Oncology Practice
|
May 30, 2025
Erratum: Outpatient Management of Bispecific Related Toxicities: An Observational Study of Safety Outcomes and Resource Utilization
Jenna R Puttkammer, Jason N Barreto, Chelsee J Jensen, et al.
Page
of 48
Search research articles
Search
Showing results (341-350 of 471) with videos related to
Sort By:
Page
of 48
American Journal of Hematology
|
June 1, 2010
A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma
Angela Dispenzieri, Gregory A Wiseman, Martha Q Lacy, et al.
Blood
|
April 17, 2012
Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial
Shaji K Kumar, Suzanne R Hayman, Francis K Buadi, et al.
Research Square
|
April 17, 2026
Risk of AL Amyloidosis is Associated with Degree of Free Light Chain Elevation and Duration of Exposure
Angela Dispenzieri, Maximilian Steinhardt, Eli Muchtar, et al.
British Journal of Haematology
|
November 20, 2020
Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma
Jithma P Abeykoon, David L Murray, Isaiah Murray, et al.
European Journal of Haematology
|
November 24, 2020
Characterization and prognostic implication of delayed complete response in AL amyloidosis
Eli Muchtar, Morie A Gertz, Shaji K Kumar, et al.
American Journal of Hematology
|
July 19, 2020
Refining amyloid complete hematological response: Quantitative serum free light chains superior to ratio
Eli Muchtar, Morie A Gertz, Martha Q Lacy, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 29, 2025
Dose Delays and Treatment Interruptions Secondary to Ocular Toxicity From BCMA-Directed Antibody Drug Conjugate Therapy in Relapsed Multiple Myeloma
Matthew J Rees, Timothy T Xu, Suheil Albert Atallah-Yunes, et al.
American Journal of Hematology
|
October 4, 2025
Clinical Characteristics, Treatment Responses and Outcomes of Light Chain Multiple Myeloma
Abiola Bolarinwa, Saurabh Zanwar, Nadine Abdallah, et al.
Blood Advances
|
January 30, 2025
Solitary plasmacytoma: single-institution experience, and systematic review and meta-analysis of clinical outcomes
Charalampos Charalampous, Jean-Sebastien Claveau, Prashant Kapoor, et al.
JCO Oncology Practice
|
May 30, 2025
Erratum: Outpatient Management of Bispecific Related Toxicities: An Observational Study of Safety Outcomes and Resource Utilization
Jenna R Puttkammer, Jason N Barreto, Chelsee J Jensen, et al.
Page
of 48